+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 75Years
FEMALE
ID07822646

Phase 3 Randomized Trial of Manganese-Primed Immunochemotherapy Versus Placebo With Anti-PD-1 and Chemotherapy in Advanced Ovarian Cancer

Led by Chinese PLA General Hospital · Updated on 2026-09-16

120

Participants Needed

6

Research Sites

88 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the use of manganese-primed immunochemotherapy in patients with advanced epithelial ovarian cancer, fallopian tube cancer, or peritoneal cancer who have relapsed and developed resistance to existing treatments. This phase III trial follows earlier studies that suggested manganese could boost the immune response to anti-PD-1 antibodies combined with chemotherapy, aiming to confirm the treatments effectiveness and safety in improving clinical outcomes. Participants receive either manganese chloride combined with anti-PD-1 antibody, nab-paclitaxel, and platinum chemotherapy, or a placebo combined with the same drugs. Treatments are given every 3 weeks until achieving a second complete response, disease progression, unacceptable side effects, or withdrawal. Manganese and placebo are inhaled twice weekly during cycles. Chemotherapy and antibody drugs are administered intravenously on specific days within each 3-week cycle. During the study, participants will undergo regular assessments including imaging to measure tumor response and progression-free survival over 12 months, along with monitoring for treatment-related side effects. Researchers will also evaluate overall survival and response rates up to 24 months. Safety and lab tests assess organ function and immune status. The trial involves frequent visits for treatment and follow-up, with a study duration lasting until disease progression or other defined endpoints.

CONDITIONS

Brief Title

A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer

Research Team

W

Weidong Han

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here